レノックス・ガストー症候群

□記事を途中から表示しています
[最初から表示]

^ “CHD2 mutations in Lennox?Gastaut syndrome”. Epilepsy Behav. 33: 18?21. (2014). doi:10.1016/j.yebeh.2014.02.005. PMID 24614520.
^ “Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency”. Eur J Med Genet. 55 (2): 132?134. (2012). doi:10.1016/j.ejmg.2011.10.004. PMID 22178256.
^ “De novo mutations in the classic epileptic encephalopathies”. Nature 501 (7466): 217?221. (2013-09-12). doi:10.1038/nature12439. ISSN 0028-0836. PMC 3773011. PMID 23934111. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773011/.
^ Lund, Caroline; Brodtkorb, Eylert; Rosby, Oddveig; Rodningen, Olaug Kristin; Selmer, Kaja Kristine (2013-07-01). “Copy number variants in adult patients with Lennox?Gastaut syndrome features”. Epilepsy Research 105 (1?2): 110?117. doi:10.1016/j.eplepsyres.2013.01.009. ISSN 1872-6844. PMID 23415449.
^ a b Hancock, EC; Cross, JH (28 February 2013). “Treatment of Lennox?Gastaut syndrome.”. The Cochrane Database of Systematic Reviews (2): CD003277. doi:10.1002/14651858.CD003277.pub3. PMID 23450537.
^ ⇒“Rufinamide: a new anti-epileptic medication”. Expert Opin Pharmacother 8 (12): 1931?40. (August 2007). doi:10.1517/14656566.8.12.1931. PMID 17696794. ⇒http://www.expertopin.com/doi/abs/10.1517/14656566.8.12.1931.
^ Sachdeo, R. C.; Glauser, TA; Ritter, F; Reife, R; Lim, P; Pledger, G (1999). ⇒“A double-blind, randomized trial of topiramate in Lennox?Gastaut syndrome”. Neurology 52 (9): 1882?7. doi:10.1212/wnl.52.9.1882. PMID 10371538. ⇒http://www.neurology.org/cgi/content/abstract/52/9/1882.
^ Alva-Moncayo, E; Ruiz-Ruiz, A (2003). ⇒“Utilidad del topiramato como terapia anadida a esquemas convencionales para el sindrome de Lennox?Gastaut [The value of topiramate used with conventional schemes as an adjunctive therapy in the treatment of Lennox?Gastaut syndrome]” (Spanish). Revista de neurologia 36 (5): 453?7. PMID 12640599. ⇒http://www.revneurol.com/sec/resumen.php?or=pubmed&id=2002014.
^ Motte, J; Trevathan, E; Arvidsson, JF; Barrera, MN; Mullens, EL; Manasco, P (1997). “Lamotrigine for generalized seizures associated with the Lennox?Gastaut syndrome. Lamictal Lennox?Gastaut Study Group”. The New England Journal of Medicine 337 (25): 1807?12. doi:10.1056/NEJM199712183372504. PMID 9400037.
^ Glaxo Wellcome Inc (1998年). “Final Printed Labeling?Part 1”. Lamictal Tablets & Chewable Dispersible Tablets (Lamotrigine) Drug Approval Page. United States Food and Drug Administration Center for Drug Evaluation and Research. 2005年4月29日時点の ⇒オリジナルよりアーカイブ。2005年11月13日閲覧。
^ Epilepsy Ontario (1999年). “ ⇒Lamotrigine Approved in Canada for Lennox?Gastaut Syndrome”. 'Sharing' News. 2005年11月13日閲覧。
^ “Felbatol (felbamate)”. p. 3. 2007年11月9日時点の ⇒オリジナルよりアーカイブ。2007年9月19日閲覧。
^ The Felbamate Study Group In Lennox?Gastaut Syndrome (1993). “Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome). The Felbamate Study Group in Lennox?Gastaut Syndrome”. The New England Journal of Medicine 328 (1): 29?33. doi:10.1056/NEJM199301073280105. PMID 8347179.
^ Devinsky, O; Faught, RE; Wilder, BJ; Kanner, AM; Kamin, M; Kramer, LD; Rosenberg, A (1995). “Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures”. Epilepsy research 20 (3): 241?6. doi:10.1016/0920-1211(94)00084-A. PMID 7796796.
^ O'neil, MG; Perdun, CS; Wilson, MB; Mcgown, ST; Patel, S (1996). “Felbamate-associated fatal acute hepatic necrosis”. Neurology 46 (5): 1457?9. doi:10.1212/wnl.46.5.1457. PMID 8628501.
^ Douglass, LM (2014). ⇒“Surgical options for patients with Lennox?Gastaut syndrome”. Epilepsia. doi:10.1111/epi.12742. ⇒http://onlinelibrary.wiley.com/doi/10.1111/epi.12742/full.
^ Lee, Yun Jin (2010). ⇒“Resective pediatric epilepsy surgery in Lennox?Gastaut syndrome”. Pediatrics. ⇒http://pediatrics.aappublications.org/content/125/1/e58.
^ Liu, SY (2012). “Surgical treatment of patients with Lennox?Gastaut syndrome phenotype”. The Scientific World Journal 2012: 614263. doi:10.1100/2012/614263. PMC 3353538. PMID 22629163. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353538/.
^ Van Rijckevorsel-Harmant, K; Delire, M; Rucquoy-Ponsar, M (1986). “Treatment of idiopathic West and Lennox?Gastaut syndromes by intravenous administration of human polyvalent immunoglobulins”. European Archives of Psychiatry and Neurological Sciences 236 (2): 119?22. doi:10.1007/BF00454021. PMID 3792407.
^ “大麻草からつくられた薬が小児の難治性てんかんに有効との研究報告” (日本語). Forbes JAPAN（フォーブスジャパン）. (2016年7月2日). https://forbesjapan.com/articles/detail/12703 2018年10月5日閲覧。
^ “ ⇒Introduction”. Lennox?Gastaut Syndrome. eMedicine.com, Inc. (2002年). 2005年7月8日閲覧。
^ Heiskala, H (1997). “Community-based study of Lennox?Gastaut syndrome”. Epilepsia 38 (5): 526?31. doi:10.1111/j.1528-1157.1997.tb01136.x. PMID 9184597.
^ Dravet, C., & Roger, J. (1996). Henri Gastaut 1915-1995. Epilepsia, 37(4), 410?415. https://doi.org/10.1111/j.1528-1157.1996.tb00580.x
^ ⇒LGS Foundation 。Lennox-Gastaut Syndrome
^ Feucht, M; Brantner-Inthaler, S (1994). “Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox?Gastaut syndrome: an open study”. Epilepsia 35 (5): 993?8. doi:10.1111/j.1528-1157.1994.tb02544.x. PMID 7925171.

次ページ

記事の検索

おまかせリスト

Size:50 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef